NL7210418A - - Google Patents
Info
- Publication number
- NL7210418A NL7210418A NL7210418A NL7210418A NL7210418A NL 7210418 A NL7210418 A NL 7210418A NL 7210418 A NL7210418 A NL 7210418A NL 7210418 A NL7210418 A NL 7210418A NL 7210418 A NL7210418 A NL 7210418A
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16703171A | 1971-07-28 | 1971-07-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7210418A true NL7210418A (pt) | 1973-01-30 |
| NL176254B NL176254B (nl) | 1984-10-16 |
| NL176254C NL176254C (nl) | 1985-03-18 |
Family
ID=22605664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7210418,A NL176254C (nl) | 1971-07-28 | 1972-07-28 | Werkwijze voor de bereiding van een anti-arrhytmische verbinding en voor de bereiding van een preparaat, dat dat bevat. |
Country Status (23)
| Country | Link |
|---|---|
| JP (1) | JPS565220B1 (pt) |
| AR (1) | AR193748A1 (pt) |
| AT (1) | AT317185B (pt) |
| AU (1) | AU476000B2 (pt) |
| BE (1) | BE786875A (pt) |
| BR (1) | BR7205069D0 (pt) |
| CA (1) | CA982148A (pt) |
| CH (1) | CH574397A5 (pt) |
| CS (1) | CS171171B2 (pt) |
| DD (1) | DD101389A5 (pt) |
| DK (1) | DK142843B (pt) |
| ES (1) | ES404739A1 (pt) |
| FI (1) | FI55492C (pt) |
| FR (1) | FR2147277B1 (pt) |
| GB (1) | GB1374367A (pt) |
| HU (1) | HU163818B (pt) |
| IE (1) | IE36607B1 (pt) |
| NL (1) | NL176254C (pt) |
| NO (1) | NO137500C (pt) |
| PL (1) | PL84891B1 (pt) |
| SE (1) | SE399702B (pt) |
| SU (1) | SU441704A3 (pt) |
| ZA (1) | ZA724512B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57182525U (pt) * | 1981-05-15 | 1982-11-19 | ||
| JPH01128053U (pt) * | 1988-02-24 | 1989-08-31 | ||
| JP2514855B2 (ja) * | 1990-08-08 | 1996-07-10 | キッセイ薬品工業株式会社 | 光学活性なアラニンアニリド誘導体の酸付加塩 |
| GB2267709A (en) * | 1992-06-11 | 1993-12-15 | Merck & Co Inc | Novel process for the preparation of alpha-aminoacylanilides |
| CA3027255C (en) | 2009-07-10 | 2022-06-21 | The General Hospital Corporation | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
| DE102012210082A1 (de) * | 2012-06-15 | 2013-12-19 | Hilti Aktiengesellschaft | Werkzeugmaschine und Steuerungsverfahren |
| JP6833811B2 (ja) | 2015-08-03 | 2021-02-24 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 荷電イオンチャネル遮断薬及び使用方法 |
| CA3129117A1 (en) | 2019-03-11 | 2020-09-17 | Bridget Mccarthy Cole | Charged ion channel blockers and methods for use |
| US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| CA3129089A1 (en) | 2019-03-11 | 2020-09-17 | Bridget Mccarthy Cole | Ester substituted ion channel blockers and methods for use |
| US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| EP3937945A4 (en) | 2019-03-11 | 2023-01-04 | Nocion Therapeutics, Inc. | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
| CA3155586A1 (en) | 2019-11-06 | 2021-05-14 | Bridget M. Cole | Charged ion channel blockers and methods for use |
| EP4054586A4 (en) | 2019-11-06 | 2023-11-22 | Nocion Therapeutics, Inc. | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
| CN115279731B (zh) | 2020-03-11 | 2024-09-13 | 诺西恩医疗公司 | 带电的离子通道阻滞剂及其使用方法 |
-
0
- BE BE786875D patent/BE786875A/xx not_active IP Right Cessation
-
1972
- 1972-06-30 ZA ZA724512A patent/ZA724512B/xx unknown
- 1972-07-04 CS CS4729A patent/CS171171B2/cs unknown
- 1972-07-04 SE SE7208768A patent/SE399702B/xx unknown
- 1972-07-07 FI FI1945/72A patent/FI55492C/fi active
- 1972-07-11 ES ES404739A patent/ES404739A1/es not_active Expired
- 1972-07-17 CA CA147,247A patent/CA982148A/en not_active Expired
- 1972-07-19 CH CH1080572A patent/CH574397A5/xx not_active IP Right Cessation
- 1972-07-20 SU SU1812965A patent/SU441704A3/ru active
- 1972-07-20 GB GB3548172A patent/GB1374367A/en not_active Expired
- 1972-07-24 DK DK365272AA patent/DK142843B/da not_active IP Right Cessation
- 1972-07-24 AU AU44886/72A patent/AU476000B2/en not_active Expired
- 1972-07-25 AR AR243250A patent/AR193748A1/es active
- 1972-07-25 NO NO2662/72A patent/NO137500C/no unknown
- 1972-07-26 PL PL1972156947A patent/PL84891B1/pl unknown
- 1972-07-27 FR FR7227161A patent/FR2147277B1/fr not_active Expired
- 1972-07-27 HU HUAA709A patent/HU163818B/hu unknown
- 1972-07-27 DD DD164729A patent/DD101389A5/xx unknown
- 1972-07-27 IE IE1058/72A patent/IE36607B1/xx unknown
- 1972-07-28 NL NLAANVRAGE7210418,A patent/NL176254C/xx not_active IP Right Cessation
- 1972-07-28 JP JP7518072A patent/JPS565220B1/ja active Pending
- 1972-07-28 BR BR5069/72A patent/BR7205069D0/pt unknown
- 1972-07-28 AT AT650472A patent/AT317185B/de active
Also Published As
| Publication number | Publication date |
|---|---|
| AU4488672A (en) | 1974-01-31 |
| NL176254B (nl) | 1984-10-16 |
| JPS565220B1 (pt) | 1981-02-04 |
| DE2235745A1 (de) | 1973-02-22 |
| IE36607L (en) | 1973-01-28 |
| BE786875A (fr) | 1973-01-29 |
| FI55492C (fi) | 1979-08-10 |
| IE36607B1 (en) | 1976-12-08 |
| DK142843B (da) | 1981-02-09 |
| CH574397A5 (pt) | 1976-04-15 |
| DE2235745B2 (de) | 1976-08-19 |
| AT317185B (de) | 1974-08-12 |
| ES404739A1 (es) | 1975-07-16 |
| ZA724512B (en) | 1973-08-29 |
| PL84891B1 (en) | 1976-04-30 |
| FI55492B (fi) | 1979-04-30 |
| CS171171B2 (pt) | 1976-10-29 |
| NL176254C (nl) | 1985-03-18 |
| DD101389A5 (pt) | 1973-11-05 |
| AR193748A1 (es) | 1973-05-22 |
| CA982148A (en) | 1976-01-20 |
| NO137500B (no) | 1977-11-28 |
| HU163818B (pt) | 1973-11-28 |
| FR2147277A1 (pt) | 1973-03-09 |
| BR7205069D0 (pt) | 1973-07-17 |
| GB1374367A (en) | 1974-11-20 |
| SU441704A3 (ru) | 1974-08-30 |
| FR2147277B1 (pt) | 1976-04-16 |
| AU476000B2 (en) | 1976-09-09 |
| NO137500C (no) | 1978-03-08 |
| DK142843C (pt) | 1981-08-31 |
| SE399702B (sv) | 1978-02-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| CNR | Transfer of rights (patent application after its laying open for public inspection) |
Free format text: AKTIEBOLAGET HAESSLE |
|
| A85 | Still pending on 85-01-01 | ||
| V4 | Discontinued because of reaching the maximum lifetime of a patent |